Aquestive Therapeutics (AQST) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Aquestive Therapeutics (AQST) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.74 Bn | 86.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.87 Bn | 32.13 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.28 Bn | 30.34 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn | -58.34% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.89 Bn | 16.57 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -14.91% |
| 10 | Aquestive Therapeutics | 466.53 Mn | 466.53 Mn | 13.47 Mn | 74.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.51% |
| Dec 31, 2025 | 609.26% |
| Sep 30, 2025 | -335.36% |
| Jun 30, 2025 | -23,879.54% |
| Mar 31, 2025 | -143.09% |
| Dec 31, 2024 | 182.24% |
| Sep 30, 2024 | -69.20% |
| Jun 30, 2024 | 101.45% |
| Mar 31, 2024 | -118.46% |
| Dec 31, 2023 | 66.06% |
| Sep 30, 2023 | 83.31% |
| Jun 30, 2023 | 90.31% |
| Mar 31, 2023 | 85.11% |
| Dec 31, 2022 | 2.96% |
| Sep 30, 2022 | -61.98% |
| Jun 30, 2022 | -176.01% |
| Mar 31, 2022 | 9.11% |
| Dec 31, 2021 | -18.37% |
| Sep 30, 2021 | 60.96% |
| Jun 30, 2021 | -1,121.46% |